Dyckerhoff Stefan A's Form 4 filing
Astera Labs, Inc.ALAB · filed Nov 9, 2026
- Accession no.
- 0001484394-26-000017
- Filed
- Nov 9, 2026, 4:44 PM ET
- Trade date
- Nov 5, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.64M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dyckerhoff Stefan ACIK 0001484394 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Common Stock | SSaleDisposed | −3,505 | $211.41 | −$740,992.05 | 43,514 | Direct | |
| Nov 5, 2026 | Common Stock | SSaleDisposed | −8,333 | $211.41 | −$1,761,679.53 | 278,067 | Indirect | |
| Nov 5, 2026 | Common Stock | SSaleDisposed | −661 | $211.41 | −$139,742.01 | 1,987 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.